Everything below concerns post-marketing surveillance. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-05-23. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Melanocortin receptor agonist |
| Molecular formula | C50H69N15O9 | Neutral form, mass near 1024.2 g/mol |
| Primary targets | MC1R, MC3R, MC4R, MC5R | Binding is non-selective across subtypes |
| Related compounds | Alpha-MSH, melanotan I, afamelanotide | Structurally or functionally related peptides |
| Common abbreviations | MT-II, MT-2 | Naming in the literature is not uniform |
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
After the war, part of the Great Chain was saved for posterity and the rest relegated to the West Point Foundry furnaces near Cold Spring, New York, to be melted down. A saved portion was first displayed at the West Point ordnance compound, along with a captured mortar, as shown in a 1905 drawing. Thirteen links are displayed at Trophy Point, one for each of the Thirteen Colonies. Also included are a swivel and clevis. The exhibit is maintained and preserved by the West Point Museum. A section of boom recovered from the river in 1855 is displayed at Washington's Headquarters State Historic Site in Newburgh, New York. Two links of the original chain are also at Raynham Hall in Oyster Bay, New York, the home of Robert Townsend, a cousin of iron works owner Peter Townsend, and (as "Culper Jr") a member of George Washington’s Culper spy ring. Bilking the gullible, John C. Abbey, and later Pollepel Island owner Francis Bannerman, sold counterfeit chain links to collectors and museums.
It tends not to share the common blue tint with a vein however. It can be felt as a hardened lump or "vein" even when the penis is flaccid, and is even more prominent during an erection. It is considered a benign physical condition. It is fairly common and can follow a particularly vigorous sexual activity for men, and tends to go away if given rest and more gentle care, for example by use of lubricants. Carcinoma of the penis is rare with a reported rate of 1 person in 100,000 in developed countries. Some sources state that circumcision can protect against this disease, but this notion remains controversial among medical circles. Hard flaccid syndrome is a rare, chronic condition characterized by a flaccid penis that remains in a firm, semi-rigid state in the absence of sexual arousal. Cold glans syndrome is a condition marked by the persistent inability of the glans penis to maintain an erect state during sexual arousal, potentially leading to reduced sensitivity and erection difficulties.
== Structure == Hepcidin is initially synthesized as an 84-amino acid preprohormone (preprohepcidin) which undergoes sequential cleavages to form the active, mature hormone. The first cleavage by signal peptidase removes the 24-amino acid N-terminal signal peptide, creating a 60-amino acid prohepcidin. Furin-like convertase and α-1 antitrypsin then cleave prohepcidin to remove a 35-amino acid proregion, resulting in the 25-amino acid mature, bioactive hepcidin. There are also shorter isoforms of hepcidin, with 20 and 22 amino acids, which have minimal iron regulatory activity. Only the 9 N-terminal amino acids are essential for hepcidin's biological activity, specifically its ability to bind to ferroportin and regulate iron metabolism. Structurally, hepcidin is a tightly folded polypeptide with 32% beta-sheet character and a hairpin tertiary structure stabilized by four disulfide bonds among eight cysteine residues (crucial structure). Hepcidin's structure has been elucidated through solution NMR, revealing that it interconverts between two conformations at different temperatures. X-ray analysis of a co-crystal with Fab confirmed a structure similar to the high-temperature NMR structure.
Sources: en.wikipedia.org
The breast augmentation procedures realised by way of IMF augmentation (through the inframammary fold), of the TABA augmentation via the armpit (trans-axillary breast augmentation), and of the TUBA augmentation via the navel (trans-umbilical breast augmentation) avoid the nipple-areola complex in order to preserve the tactile sensitivity of the areola and the breastfeeding functions. Moreover, two conditions most affect and interfere with the functioning of the lactiferous ducts: (i) the subglandular implantation of the prosthetic breast, and (ii) the implantation of oversized prosthetic-breasts. Therefore, the implantation of small prosthetic breasts and a submuscular implant-pocket are the breast-augmentation surgeries that least thwart the breastfeeding function.
A blood smear is a thin layer of blood smeared on a glass microscope slide and then stained in such a way as to allow the various blood cells to be examined microscopically. This technique can be used to detect sickled cells visually; however, it does not detect sickle cell carriers. A solubility test relies on the fact that HbS is less soluble than normal haemoglobin (HbA); it is highly reliable but does not distinguish between full sickle cell disease and carrier status. Tests which can be used for sickle cell disease as well as for other hemoglobinopathies:
Harris (1988), expert on African-American history at Northwestern University Claudio Saunt (1989), professor at the University of Georgia, author of Unworthy Republic Nicholas Birns (1988), Tolkien scholar William H. Sherman (1988), director of the Warburg Institute, University of London Stephanie Stebich (1988), director of Smithsonian American Art Museum Stephanos Bibas (1989), professor of law and criminology at the University of Pennsylvania Law School, judge for the United States Court of Appeals for the Third Circuit Karen Chapple (1989), scholar of Urban planning at University of California, Berkeley Jesús Escobar (1989), professor of Art History at Northwestern University, expert in early modern art of Spain and Italy Daniel Halberstam (1989), professor of law at the University of Michigan Law School Stephanie Aaronson (1990), economist and vice president of Brookings Institution Rhea Anastas (1990), art historian, critic, curator and professor at University of California, Irvine Matthew Connelly (1990), professor of international and global history at Columbia University Juliet Koss (1990), art historian, professor at Scripps College Jennifer Lee (1990), sociologist, professor of Columbia University Catherine Prendergast (1990), professor of English at University of Illinois Urbana-Champaign Benjamin Frommer (1991), historian, professor at Northwestern University Mary Pattillo (1991), professor of African-American studies at Northwestern University Cynthia A. Young (1991), professor of African-American studies at Pennsylvania State University Robert T.
Sources: en.wikipedia.org
The filtrate can be re-used by adding more dimethylurea and glyoxal (no additional catalyst is needed) and obtaining respectable yields, although this requires a longer reaction time. As of 2021, temgicoluril has not been evaluated outside of Latvia and Russia.
== Medical uses == Trilaciclib is indicated to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.
==== Nematodes ==== For example, in the roundworm Caenorhabditis elegans, which feeds on bacteria, serotonin is released as a signal in response to positive events, such as finding a new source of food or in male animals finding a female with which to mate. When a well-fed worm feels bacteria on its cuticle, dopamine is released, which slows it down; if it is starved, serotonin also is released, which slows the animal down further. This mechanism increases the amount of time animals spend in the presence of food. The released serotonin activates the muscles used for feeding, while octopamine suppresses them. Serotonin diffuses to serotonin-sensitive neurons, which control the animal's perception of nutrient availability.
Little is known of the reproductive behavior of the white shark. There are two anecdotal accounts of the species possibly mating, one in 1991 and another in 1997, both off New Zealand. These testimonies both report belly-to-belly rolling during copulation. Researchers assume that the male bites onto the female's head or fin while inserting one of his claspers (sex organs), as is the case in other shark species. The accounts also suggest that white sharks mate in shallow water away from feeding areas. Females at Guadalupe and Cape Cod have been seen with scarring that may have been the result of copulation, possible evidence that these areas are used for mating. Conversely, other studies have concluded that white sharks may mate offshore; males off western North America were found to gather in the open ocean during spring and were followed by some females, suggesting a lek mating system where females move through and choose their partners. In 2013, it was proposed that whale carcasses are an important location for sexually mature sharks to meet for mating, especially with the frenzied excitement. Captures of pregnant females have provided key insights into the species's reproduction. The white shark is ovoviviparous; fertilized eggs hatch within the female, and the embryos continue to develop within each uterus. Their nourishment comes in three stages: they first feed on their yolk sacs, then a milky substance secreted by the uterus known as lipid histotrophy, and finally switch to consuming unfertilized eggs.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.
Activation of MC1R increases pigment synthesis independently of ultraviolet exposure, which is the mechanism usually cited for darkening without sun exposure. Ultraviolet light still influences skin response through separate biological pathways.
Because the peptide binds several melanocortin receptor subtypes, its effects are not confined to pigmentation. This complicates interpretation of both intended and unintended outcomes reported in studies.
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.